Pluribus Labs’s Aptiv APTV Stock Holding History

Pluribus Labs’s Portfolio APTV Stock Details APTV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-1,291	Closed	-$213K	–	64
2021 Q4	$213K	Buy	+1,291	New	+$215K	0.22%	203

Other funds holding APTV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Pluribus Labs's APTV Position: Q1 2022 in Review

Pluribus Labs sold out of Aptiv (APTV) in Q1 2022, closing a stake of 1,291 shares — an estimated $213K sold.

Pluribus Labs first reported a position in APTV in Q4 2021 and held it in 1 quarter. The position peaked at $213K in Q4 2021. 758 funds tracked by Wall St. Rank hold APTV as of Q1 2022.

Pluribus Labs reported no remaining Aptiv position as of Q1 2022 after selling out during the quarter.
Pluribus Labs sold 1,291 Aptiv shares in Q1 2022, an estimated $213K.
Pluribus Labs first reported a position in Aptiv in Q4 2021 and held it in 1 quarter.
Pluribus Labs's Aptiv position peaked at $213K in Q4 2021.
758 funds tracked by Wall St. Rank held Aptiv as of Q1 2022.

Based on Pluribus Labs's 13F filing for Q1 2022, filed 16 May 2022.